Tag: biologics

Rheumatoid arthritis treatment relies on DMARDs and biologics to slow joint damage. Methotrexate remains first-line, but biologics and JAK inhibitors offer powerful alternatives when needed. Understanding how they interact-and their risks, costs, and timing-helps patients make smarter choices.

Biosimilars aren't exact copies of biologics - tiny manufacturing differences can trigger immune responses. Learn why some patients develop anti-drug antibodies and how regulators ensure safety despite these variations.